Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
12
Frequently Asked Questions
What is Market Cap of Dogwood Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Dogwood Therapeutics Inc. market cap is $9.9M.
What is the 52-week high for Dogwood Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Dogwood Therapeutics Inc. 52 week high is $29.28 as of September 24, 2025.
What is the 52-week low for Dogwood Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Dogwood Therapeutics Inc. 52 week low is $1.62 as of September 24, 2025.
What is Dogwood Therapeutics Inc. stock price today?
Dogwood Therapeutics Inc. stock price today is $5.03.
What was Dogwood Therapeutics Inc. stock price yesterday?
Dogwood Therapeutics Inc. stock price yesterday was $5.18.
What is the PE ratio of Dogwood Therapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Dogwood Therapeutics Inc.’s P/E ratio is -0.28.
What is the Price-to-Book ratio of Dogwood Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Dogwood Therapeutics Inc. P/B ratio is -0.5465.
What is the 50-day moving average of Dogwood Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Dogwood Therapeutics Inc. 50-day moving average is $4.87.
How many employess does Dogwood Therapeutics Inc. has?